← Back to All Filings

Acrivon Therapeutics CLO Sells $944 in Tax Withholding Trade

Low SignificanceOctober 26, 2026 at 4:05:17 PM EDT

Acrivon Therapeutics, Inc.

$ACRV4CIK: 0001781174

Subscribe to track ACRV

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Acrivon Therapeutics CLO Sells $944 in Tax Withholding Trade

Company: Acrivon Therapeutics, Inc. (ACRV) Form: 4 | Filed: 2026-10-26 Significance: Low

Insider: Mary Miller Title: Chief Legal Officer | Relationship: Officer

Transaction: • Type: Sell (Automatic Tax Withholding) • Shares: 513 • Price: $1.84 • Value: $943.92 • Owned After: 81,202

Key Insight: This transaction represents an automatic sale of 513 shares exclusively to satisfy mandatory tax withholding requirements upon RSU vesting, with zero discretionary selling involved.

Market Context: At under $1,000 (0.001% of market cap), this non-discretionary transaction carries no informational signal regarding company fundamentals.

Comprehensive Analysis

SEC Filing Analysis: Acrivon Therapeutics, Inc. (ACRV)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Chief Legal Officer Mary Miller disposed of 513 shares at $1.84 ($943.92 total) automatically to satisfy mandatory tax withholding obligations upon RSU vesting.
  • Market Impact: Neutral; routine administrative sell-to-cover transaction with negligible financial materiality.

Company Information

FieldValue
CompanyAcrivon Therapeutics, Inc.
Ticker SymbolACRV
CIK0001781174
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameMary Miller
CIK0001841088
Title/PositionChief Legal Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-10-22
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved513
Price Per Share$1.84
Total Value$943.92
Shares Owned After81,202
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$943.92
% of Market Cap ($70M)0.0013%
Shares Transacted513
% of Shares Outstanding (42.85M)0.0012%
Post-Transaction Ownership81,202 shares (0.19% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Against a market cap of approximately $70 million, the sub-$1,000 transaction value is immaterial.
  • Ownership Concentration: Mary Miller maintains 81,202 directly held shares (0.19% of outstanding stock), reducing her position by less than 0.63% through this event.
  • Dilution Impact: None; the transaction reflects an open-market disposition of vested shares.
  • Transaction Significance: Low significance given the de minimis size and automatic non-discretionary mandate.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Automatic sell-to-cover tax withholding transactions do not signal insider sentiment or operational inflection points.

Volume & Sentiment

  • Expected Volume Impact: Negligible; 513 shares will have zero observable market liquidity impact.
  • Sentiment Indicator: Neutral

Additional Context

Transaction Notes

  • Special Circumstances: The disposition was executed automatically by a broker pursuant to mandatory tax withholding requirements tied to RSU vesting, as confirmed in Footnotes 1 and 2.
Topics:#SECFiling#ACRV#Form4#InsiderTrading#BiotechStocks#StockAlert#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.